August 9, 2007 AEGON continues strong operational performance and announces EUR 1 billion share repurchase program

 

  • BUSINESS GROWTH AND INVESTMENT PERFORMANCE DRIVE EARNINGS GROWTH:
    • Net operating earnings up 22%, on pro forma basis, to EUR 570 million*
    • Net underlying operating earnings up 9%, on pro forma basis, to EUR 532 million*

 

  • NET INCOME DOWN 24% TO EUR 655 MILLION:
    • Decrease mainly in the Netherlands due to release of guarantee provisions in second quarter 2006 and declining fair value of derivatives in second quarter 2007
    • Recent change in Dutch hedging and investment strategy is expected to limit derivatives impact on net income going forward

 

  • STRONG INCREASE IN NEW LIFE SALES AND TOTAL DEPOSITS

 

  • CONTINUED PROFITABLE GROWTH IN VALUE OF NEW BUSINESS

  • AEGON ENHANCES SHAREHOLDER RETURN**:
    • Intention to repurchase EUR 1 billion of common shares by end 2007
    • Increase in interim dividend by 25% to EUR 0.30 per share

 
* For notes see page 27 of the full press release.

* 2007 is compared to pro forma data for 2006. These figures are presented after the change in accounting principles and after the change in definition of operating earnings to include our share in net results of associates and exclude the effect of any movements in the fair value of guarantees, as would have been the case had AEGON The Netherlands' hedge program been in place for 2006. Net income is, however, only affected by the change in the accounting principles. See also table Financial Overview on page 3 of the full release and AEGON's press release of 24 July 2007.


** A separate press release will be issued today



CHAIRMAN'S OVERVIEW
"The increases we are reporting today in net operating earnings, new life sales, value of new business and continued improvement in our internal rate of return, indicate that AEGON's businesses performed well during the second quarter.

"The 22% increase in net operating earnings for the quarter reflects growth across all geographies and most lines of business. This growth was partially offset by a weaker US dollar. The strong performance of AEGON's investment portfolio, as well as the organic growth of our business contributed to the increase in our earnings.

"The value of new business generated for the Group increased 28% in the quarter with all AEGON's country units contributing to the increase.

"A record quarter in the United Kingdom helped the Group achieve sales growth of 9% in the second quarter, as did continued strong sales in Poland and the bank partnerships in Spain. In Taiwan, we also experienced strong sales of unit-linked products, continuing our successful shift away from more traditional life products.

"In the Americas, we were pleased by the 12% increase in variable annuity sales during the quarter, with May being the highest since 2003. Retail sales increased 11% in the second quarter, helped by particularly strong sales within our agency channel, continuing a trend first seen in the fourth quarter of last year.

"Due primarily to higher pension sales, new life sales in the Netherlands showed a 6% increase. Late last month, we announced a change in accounting principles with regard to the valuation of guarantees on certain products in the Netherlands, ensuring that our financial statements better reflect the economic matching of assets and liabilities.


"Within AEGON UK, new life sales increased 9% over the year-ago period, resulting in another record quarter for our UK business. The increase reflects strong growth across most product lines, including continued increases in pension sales post-A day.

"Given continuing concerns over investments backed by sub-prime mortgages in the United States, it is worth emphasizing that our portfolio has been structured to weather a stressful credit environment. The majority of our sub-prime exposure is backed by fixed-rate mortgages and is rated triple-A. None of our holdings was included in the recent rating agency downgrades. We have insignificant exposure to subprime Collateralized Debt Obligations (CDOs). AEGON will continue to closely monitor developments in this market, but does not expect material impairments to its holdings."


"We have also enhanced shareholder return with a EUR 1 billion share buy-back and an increased interim dividend. The return of excess capital to shareholders will not hamper AEGON's ability to invest in the growth of its businesses or to accomplish add-on acquisitions.

"In summary, our businesses in the Americas, Europe, and Asia achieved further progress toward the goal we outlined last year to double the value of new business by 2010. Improvements in earnings, sales and profitability indicate that the performance of AEGON's businesses remains strong."


DISCLAIMERS

Local currencies and constant currency exchange rates
This press release contains certain information about our results and financial condition in USD for the Americas, GBP for the United Kingdom, HUF for Hungary and NTD for Taiwan because those businesses operate and are managed primarily in those currencies. Certain comparative information presented on a constant currency basis eliminates the effects of changes in currency exchange rates. None of this information is a substitute for or superior to financial information about us presented in EUR, which is the currency of our primary financial statements.

 

Forward looking statements
The statements contained in this press release that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as 'believe', 'estimate', 'target', 'intend', 'may', 'expect', 'anticipate', 'predict', 'project', 'counting on', 'plan', 'continue', 'want', 'forecast', 'should', 'would', 'is confident' and 'will' and similar expressions as they relate to us are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. We undertake no obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates.

All forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from expectations, including, but not limited to, the following:

  • Changes in general economic conditions, particularly in the United States, the Netherlands and the United Kingdom;
  • Changes in the performance of financial markets, including emerging markets, including:
      • The frequency and severity of defaults by issuers in our fixed income investment portfolios; and
      • The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in value of equity and debt securities we hold;
  • The frequency and severity of insured loss events;
  • Changes affecting mortality, morbidity and other factors that may affect the profitability of our insurance products;
  • Changes affecting interest rate levels and continuing low interest rate levels and rapidly changing interest rate levels;
  • Changes affecting currency exchange rates, including the EUR/USD and EUR/GBP exchange rates;
  • Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets;
  • Changes in laws and regulations, particularly those affecting our operations, the products we sell and the attractiveness of certain products to our consumers;
  • Regulatory changes relating to the insurance industry in the jurisdictions in which we operate;
  • Acts of God, acts of terrorism, acts of war and pandemics;
  • hanges in the policies of central banks and/or foreign governments;
  • Litigation or regulatory action that could require us to pay significant damages or change the way we do business;
  • Customer responsiveness to both new products and distribution channels;
  • Competitive, legal, regulatory, or tax changes that affect the distribution cost of or demand for our products;
  • Our failure to achieve anticipated levels of earnings or operational efficiencies as well as other cost saving initiatives;
  • The impact on our reported financial results and financial condition as a result of our adoption of International Financial Reporting Standards.



 

CONTACT INFORMATION 

Group Corporate Affairs & Investor Relations

 

The Hague, the Netherlands

 

Analysts & investors

+31 (0)70 344 83 05

Media +31 (0)70 344 83 44
E-mail gca-ir@aegon.com

Baltimore, the United States

 

Analysts & investors

877 548 9668 (toll free - USA only)

+1 410 576 45 77

Media +1 410 576 45 26
E-mail ir@aegonusa.com




Last update: Mar 5, 2008